|
GOLGA2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.589400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.588200E-01 |
| Normal-vs-Stage2 |
7.947000E-01 |
| Normal-vs-Stage3 |
8.010200E-01 |
| Normal-vs-Stage4 |
4.425800E-01 |
| Stage1-vs-Stage2 |
8.514400E-01 |
| Stage1-vs-Stage3 |
8.286000E-01 |
| Stage1-vs-Stage4 |
6.098200E-01 |
| Stage2-vs-Stage3 |
9.960000E-01 |
| Stage2-vs-Stage4 |
5.715400E-01 |
| Stage3-vs-Stage4 |
5.926800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.765000E-01 |
| Normal-vs-AfricanAmerican |
5.621200E-01 |
| Normal-vs-Asian |
7.512400E-02 |
| Caucasian-vs-AfricanAmerican |
5.140800E-01 |
| Caucasian-vs-Asian |
2.416000E-01 |
| AfricanAmerican-vs-Asian |
2.936800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.475400E-01 |
| Normal-vs-Female |
4.291800E-01 |
| Male-vs-Female |
1.950840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.521800E-02 |
| Normal-vs-Extreme_Weight |
5.513200E-01 |
| Normal-vs-Obese |
2.433800E-01 |
| Normal-vs-Extreme_Obese |
6.644400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.189800E-01 |
| Normal_Weight-vs-Obese |
1.029500E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.643400E-01 |
| Extreme_Weight-vs-Obese |
9.261800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.804400E-01 |
| Obese-vs-Extreme_Obese |
3.919400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.910400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.505350E-01 |
| Normal-vs-Age(61-80Yrs) |
1.145180E-01 |
| Normal-vs-Age(81-100Yrs) |
3.373200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.377000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.844800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.495600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.795700E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.810810E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.752000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.275600E-01 |
| Normal-VS-Type2 PRCC |
1.255640E-02 |
| Normal-VS-KIRP CIMP |
2.780000E-01 |
| Normal-VS-Unclassified PRCC |
4.264200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.649200E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.657600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.559200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.084500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.376300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.793800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.600040E-01 |
| Normal-vs-N1 |
9.680000E-01 |
| Normal-vs-N2 |
7.845000E-01 |
| N0-vs-N1 |
2.777600E-01 |
| N0-vs-N2 |
3.410200E-01 |
| N1-vs-N2 |
7.081000E-01 |
|
|
